Get the Stockscreener App
24.30
2.23%
0.53
Privia Health Group Inc stock is traded at $24.30, with a volume of 831.55K.
It is up +2.23% in the last 24 hours and up +10.40% over the past month.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
See More
Previous Close:
$23.77
Open:
$23.98
24h Volume:
831.55K
Relative Volume:
1.12
Market Cap:
$2.99B
Revenue:
$1.80B
Net Income/Loss:
$15.62M
P/E Ratio:
202.50
EPS:
0.12
Net Cash Flow:
$118.36M
1W Performance:
+7.28%
1M Performance:
+10.40%
6M Performance:
+5.10%
1Y Performance:
-4.78%
1-Day Range:
$23.33
$24.46
1-Week Range:
$22.48
$25.22
52-Week Range:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
24.30 | 2.92B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
Privia Health Earnings Call Highlights Growth And Cash - TipRanks
PRVA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Privia Health Soars 9.98% to Hit Intraday High of $25.16 - Markets Mojo
Breaking Down Privia Health Gr: 5 Analysts Share Their Views - Benzinga
Citigroup Issues Pessimistic Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - marketscreener.com
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration – Company AnnouncementFT.com - Financial Times
Privia Health price target raised to $33 from $31 at Truist - Yahoo Finance
Royce & Associates LP Buys 214,166 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
Matthew Shawn Morris Sells 16,550 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Matthew Shawn Morris Sells 7,788 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 7,697 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,361 Shares - MarketBeat
Privia Health Group Insider Sold Shares Worth $326,835, According to a Recent SEC Filing - marketscreener.com
Privia Health (PRVA) director sells 24,338 shares after option exercise - Stock Titan
Privia (NASDAQ: PRVA) CFO sells 13,058 shares via 10b5-1 plan - Stock Titan
PRVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Truist Adjusts Price Target on Privia Health to $33 From $31, Maintains Buy Rating - marketscreener.com
Jefferies Maintains Buy on PRVA Privia Health Group, Inc. Feb 2026 - Meyka
Privia Health Group (PRVA) Is Up 8.0% After Earnings Beat And Higher 2026 Revenue Outlook – Has The Bull Case Changed? - simplywall.st
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Privia Health Group (PRVA) Is Up 8.0% After Raising 2026 Revenue Guidance and Beating Q4 Targets - Yahoo Finance
Privia Health Gr (PRVA) Receives Buy Rating with Increased Price Target | PRVA Stock News - GuruFocus
Decoding Privia Health Group Inc (PRVA): A Strategic SWOT Insigh - GuruFocus
PRVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - The Globe and Mail
Canaccord Genuity Group Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Wall Street Analysts Think Privia Health (PRVA) Could Surge 25.45%: Read This Before Placing a Bet - sharewise.com
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2025 Earnings Call Transcript - Insider Monkey
Privia Health Group, Inc. SEC 10-K Report - TradingView
Privia Health (Nasdaq: PRVA) expands value-based care footprint - Stock Titan
Privia Health Group Q4 Earnings Call Highlights - Yahoo Finance
Privia Health Group (NASDAQ:PRVA) Issues Earnings Results - MarketBeat
Piper Sandler raises Privia Health stock price target on strong results By Investing.com - Investing.com South Africa
Privia Health: Q4 Earnings Snapshot - theheraldreview.com
Earnings Call Summary | Privia Health(PRVA.US) Q4 2025 Earnings Conference - 富途牛牛
Insider sale notice: 23,887 shares sold (NASDAQ: PRVA) - Stock Titan
Jefferies raises Privia Health stock price target on strong quarter - Investing.com
Piper Sandler raises Privia Health stock price target on strong results - Investing.com India
Privia Health Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PRVA) 2026-02-26 - Seeking Alpha
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Privia Health Group Breaks Above 200-Day Moving AverageBullish for PRVA - Nasdaq
Privia Health Q4 2025 slides: EBITDA surges 39%, guidance strong - Investing.com
Privia Health Group (NASDAQ:PRVA) Stock Price Up 9.4% Following Earnings Beat - MarketBeat
Earnings call transcript: Privia Health Q4 2025 earnings soar past expectations - Investing.com Nigeria
Privia Health (PRVA) Q4 2025 Earnings Transcript - The Globe and Mail
Privia Health Q4 2025 slides: EBITDA surges 39%, guidance strong By Investing.com - Investing.com UK
Privia Health Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Privia Health (NASDAQ:PRVA) Reports Strong Q4 CY2025 - Finviz
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
3.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):